Trying to get good sleep when you have chronic pain is often a challenge. A 2015 Sleep in AmericaTM poll found that people with pain are likely to report daily sleep problems. In fact, sleep complaints are reported to be present in 67-88% of chronic pain disorders. Whether pain prevents you from sleeping or interferes with your quality of sleep, chronic pain can be a nightmare for some people.
When it comes to treating chronic pain, pain lasting longer than 3 months or past the time of normal tissue healing, there are a lot of opinions, ideas and misinformation out there. While there is still much to be studied about the treatment of chronic pain, we do have data to help dispel common myths about chronic pain treatment.
Endo Pharmaceuticals Inc. recently released news that it will voluntarily remove Opana ER from the market, with planned shipments slated to end September 1, 2017. This news follows the Food and Drug Administration’s (FDA) June 2017 request to withdraw Opana ER from the market due to risks related to abuse.
With opioid abuse and misuse so prevalent today, it is important to understand the scale of the issue and be aware that certain factors might put you or someone you know at risk for developing opioid addiction, abuse, harm or misuse.
Topical compound medications are typically not the first choice for treatment of pain from a workplace injury, but they can be useful in some situations.
According to the FDA, nearly 8 in 10 prescriptions filled in the United States are for generic drugs. That statistic may lead to the question, what are generic drugs and why are they apparently used more often than brand drugs? To answer that question, it is important to understand a little bit about how drugs are developed and come to market.
The terms opiate, opioid and narcotic are often used in what would seem the same way. With prescription pain medications reaching their highest point in years, it’s wise to know the difference between each of these terms and how they work.
Tamper resistant and abuse deterrent opioid formulations are designed to make drugs difficult or less desirable to use in any manner other than how they were prescribed. The formulations make them harder to crush, chew, cut, dissolve, inhale, inject, or less rewarding if done so, thus deterring use in many of the ways they are abused. With the goal of combatting the opioid epidemic, the “FDA is encouraging the development of opioid formulations with abuse-deterrent properties”.
It’s become clear that excessive use of opioids is a problem. According to the Centers for Disease Control and Prevention (CDC), prescription opioids are considered a driving force in the 15-year increase in opioid-related deaths with 91 Americans dying every day from an opioid overdose. What can be done to decrease these overdoses? Many factors and opinions play into the decisions around how best to tackle this problem.
When it comes to taking medications, it’s important to make decisions about continuing, changing or stopping them based off an understanding of the potential for both risks and benefits. Medications should only be used if the benefits outweigh the potential harms or risks.